GB590-Unit6-Case-Analysis-GB590-01NCorporate Social Responsibility.DOCX

GB590-Unit6-Case-Analysis-GB590-01NCorporate Social Responsibility

Unit 6Case Analysis: Ventria Bioscience and the Controversy over Plant-Made Medicines

Kaplan University

Graduate School of Business and Management

GB590-01NCorporate Social Responsibility

Dr. Charles Needham





VentriaBioscience and the Controversy over Plant-Made Medicines


The aim of this analysis will be to determine what the best course of action for Ventria Bioscience will be for handling the current controversy over plant-made medicines. This study will examine the situation by analyzing the problem faced by the company, discussing the triple bottom line implications, and proposing a solution. As a result of this evaluation, the proposed recommendation will provide a strategy for what Ventria should do to respond to this situation for the most beneficial outcome.

Company Overview


Powered by